Ganga Pharmaceuticals Q4 Results
- BSE: 539680
- NSE: -
- ISIN: INE615T01017
- Sector: Biotechnology & Drugs
BSE
12.50
0.00 (0.00%)
0.00 (0.00%)Volume0.00
Updated: Tue 8 Sep, 2026 | 16:00:04
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹1.46 Cr.(10.20%)
- Operating Profit₹0.03 Cr.(NA%)
- Profit After Tax₹0.08 Cr.(39.55%)
- Operating Margin2.14%(NA%)
Note: Comparison is on YoY basis
Quarterly - Ganga Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | - | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1.43 | - | N/A | 1.43 | 5.73% |
| Depreciation/ Amortization | 0.03 | - | N/A | 0.02 | 35.25% |
| Operating Income | 0.03 | - | N/A | -0.02 | 0.00% |
| Net Income | 0.08 | - | N/A | 0.03 | 39.55% |
| Net Income Before Taxes | 0.10 | - | N/A | 0.04 | 248.64% |
| Other Operating Expenses Total | 0.45 | - | N/A | 0.46 | 2.09% |
| Total Revenue | 1.46 | - | N/A | 1.42 | 10.20% |
| Selling/ General/ Admin Expenses Total | 0.27 | - | N/A | 0.33 | -7.12% |
| Diluted Normalized EPS | 0.14 | - | N/A | 0.03 | 107.42% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.